1
|
Pfragner R, Höfler H, Behmel A, Ingolic E
and Walser V: Establishment and characterization of continuous cell
line MTC-SK derived from a human medullary thyroid carcinoma.
Cancer Res. 50:4160–4166. 1990.PubMed/NCBI
|
2
|
Herold G: Innere Medizin. Herold; Köln:
pp. 743–745. 2012, In German.
|
3
|
Nicolini V, Cassinelli G, Cuccuru G,
Bongarzone I, Petrangolini G, Tortoreto M, Mondellini P, Casalin P,
Favini E, Zaffaroni N, Zunino F and Lanzi C: Interplay between Ret
and Fap-1 regulates CD95-mediated apoptosis in medullary thyroid
cancer cells. Biochem Pharmacol. 82:778–788. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Schulten HJ, Al-Maghrabi J, Al-Gahmdi K,
Salama S, Al-Muhayawi S, Chaudhary A, Hamour O, Abuzenadah A, Gari
M and Al-Qhatani M: Mutational screening of RET, HRAS, KRAS, NRAS,
BRAF, AKT1 and CTNNB1 in medullary thyroid carcinoma. Anticancer
Res. 31:4179–4183. 2011.PubMed/NCBI
|
5
|
Li ZX, Sturm S, Stuppner H, Schraml E,
Aguiriano-Moser V, Siegl V and Pfragner R: The dichloromethane
fraction of Stemona tuberosa Lour inhibits tumor cell growth and
induces apoptosis of human medullary thyroid carcinoma cells.
Biologics: Targets and Therapy. 1:455–463. 2007.
|
6
|
Li Z, Sturm S, Svejda B, Höger H, Schraml
E, Ingolic E, Siegl V, Stuppner H and Pfragner R: Anticancer
activity of novel extracts from Cautleya gracilis (Smith) Dandy:
apoptosis in human medullary thyroid carcinoma cells. Anticancer
Res. 28(5A): 2705–2713. 2008.PubMed/NCBI
|
7
|
Svejda B, Aguiriano-Moser V, Sturm S,
Höger H, Ingolic E, Siegl V, Stuppner H and Pfragner R: Anticancer
antivity of novel plant extracts from Trailliaedoxa gracilis (W.W.
Smith & Forrest) in human carcinoid KRJ-I cells. Anticancer
Res. 30:55–64. 2010.PubMed/NCBI
|
8
|
Rinner B, Siegl V, Pürstner P, Efferth T,
Brem B, Greger H and Pfragner R: Activity of novel plant extracts
against medullary thyroid carcinoma cells. Anticancer Res. 24(2A):
495–500. 2004.PubMed/NCBI
|
9
|
Rinner B, Li ZX, Haas H, Siegl V, Sturm S,
Stuppner H and Pfragner R: Antiproliferative and pro-apoptotic
effects of Uncaria tormentosa in human medullary thyroid carcinoma
cells. Anticancer Res. 29:4519–28. 2009.PubMed/NCBI
|
10
|
Tappeiner J: Phytochemische Untersuchungen
zu Trailliaedoxa gracilis,Diplomarbeit zur Erlangung des
akademischen Grades Magistra der Pharmazie an der Leopold Franzens
Universität Innsbruck. pp. 15–50. 2007, In German.
|
11
|
Handel-Mazzetti H: Naturbilder aus
Südwest-China Erlebnisse und Eindrücke eines österreichischen
Forschers während des Weltkrieges. Österreichischer Bundesverlag;
Wien-Leipzig: pp. 3801927, In German.
|
12
|
Wu Hao, Zeng Liangqing and Gong Xun:
Chromosome number of Traillaedoxa gracilis (Rubiaceae) endemic to
jinsha river valley. Acta Botanica Yunnanica. 32:407–408. 2010.
|
13
|
Pathak AK, Bhutani M and Nair AS: Ursolic
acid inhibits STAT3 activation pathway leading to supression of
proliferation and chemosensitization of human myeloma cells. Mol
Canc Res. 5:943–955. 2007. View Article : Google Scholar
|
14
|
Liobikas J, Majiene D, Trumbeckaite S,
Kursvietiene K, Masteikova R, Kopustinkinene DM, Savickas A and
Bernatoniene J: Uncoupling and antioxidant effects of ursolic acid
in isolated rat heart mitochondria. J Nat Prod. 74:1640–1644. 2011.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Wu WY, Li J, Wu ZS, Zhang CL and Meng XL:
STAT3 activation in monocytes accelerates liver cancer progression.
BMC Cancer. 11:5062011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Liu Q, Liu S, Shi Y, Li H, Hao J, Xing L,
Cao Y and Duan H: Suppressors of cytokine signaling inhibit
tubular, epithelial cell-myofibroblast transdifferentiation. Am J
Nephrol. 34:142–151. 2011. View Article : Google Scholar
|
17
|
Li X, Massa PE, Hanidu A, Peet GW, Aro P,
Savitt A, Mische S, Li J and Marcu KB: IKKalpha, IKKbeta and
NEMO/IKKgamma are each required for the NF-kappa B-mediated
inflamatory response program. J Biol Chem. 277:45129–45140. 2002.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Miyamoto S: Nuclear initiated NF-κB
signaling: NEMO and ATM take center stage. Rev Cell Res.
21:116–130. 2011. View Article : Google Scholar
|
19
|
Rudolph D, Yeh WC, Wakeham A, Rudolph B,
Nallainathan D, Potter J, Elia AJ and Mak TW: Severe liver
degeneration and lack of NF-kappaB activation in
NEMI/IKKgamma-deificient mice. Genes De. 14:854–862. 2000.
|
20
|
Legarda-Addison D, Hase H, O'Donnell MA
and Ting AT: NEMO/IKKgamma regulates an early NF-kappaB-independent
cell death checkpoint during TNF signaling. Cell Death Differ.
16:1297–1288. 2009. View Article : Google Scholar
|
21
|
Kojima H, Sasaki T, Ishitani T, Iemura S,
Zhao H, Kaneko S, Kunimoto H, Natsume T, Matsumoto K and Kakajima
K: STAT3 regulates nemo-like kinase by mediating its interaction
with IL-6-stimulated TGFbeta-activated kinase 1 for STAT3 Ser 727
phosphorilation. Proc Natl Acad Sci USA. 102:4524–4529. 2005.
View Article : Google Scholar
|
22
|
Wolf C, Lederer K, Pfragner R,
Schauenstein K, Ingolic E and Siegl V: Biocompatibility of
ultra-high molecular weight polyethylene (UHMW-PE) stablized with
alpha-tocopherol used for joint endoprotheses assessed in vitro. J
Mater Sci Mater Med. 18:1247–1252. 2007. View Article : Google Scholar : PubMed/NCBI
|
23
|
Pfragner R, Behmel A, Ingolic E and
Wirnsberger GH: Culture of human neuroendocrine tumor cells.
Culture of Specialized Cells: Culture of human tumor cells.
Pfragner R and Freshney RI: John Wiley & Sons, Inc; Hoboken,
New Jersey: pp. 373–403. 2004
|
24
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
25
|
Aggarwal BB and Shishodia S: Molecular
targets of dietary agents for prevention and therapy of cancer.
Biochem Pharmacol. 71:1397–1421. 2006. View Article : Google Scholar : PubMed/NCBI
|
26
|
Pfragner R, Wirnsberger G, Behmel A, Wolf
G, Passath GA, Ingolic E and Adamiker D: New continuous cell line
from human medullary carcinoma: SINJ. Phenotypic analysis and in
vivo carcinogenesis. Int J Oncol. 2:831–836. 1993.PubMed/NCBI
|
27
|
Pfragner R, Wirnsberger G, Ingolic E and
Niederle B: Medullary thyroid carcinomas in cell culture - models
for future therapies. Wien Klin Wochenschr. 114:279–283.
2002.PubMed/NCBI
|
28
|
Pfragner R, Wirnsberger G, Niederle B,
Behmel A, Rinner I, Mandl A, Wawrina F, Luo JS, Adamiker D, Höger
H, Ingolic E and Schauenstein K: Establishment of a continuous cell
line from a human carcinoid of the small intestine (KRJ-I):
Characterization and effects of 5-azacytidine on proliferation. Int
J Onc. 8:513–520. 1996.
|
29
|
Kimhi Y, Palfrey C, Spector I, Barak Y and
Littauer UZ: Maturation of neuroblastoma cells in the presence of
dimethyl-sulfoxide. Proc Nat Acad Sci USA. 73:462–466. 1976.
View Article : Google Scholar
|
30
|
Mitaka T, Norioka K, Nakamura T and
Mochizukio Y: Effects of mitogens and co-mitogens on the formation
of small-cell colonies in primary cultures of rat hepatocytes. J
Cell Physiol. 157:461–468. 1993. View Article : Google Scholar : PubMed/NCBI
|
31
|
Rudland PS: Use of peanut lectin and rat
mammary stem cell lines to identify a cellular differentiation
pathway for the alveolar cell in the rat mammary gland. J Cell
Physiol. 152:157–168. 1992. View Article : Google Scholar
|
32
|
Da Violante G, Zerrouk N, Richard I,
Provot G, Chaumeil JC and Arnaud P: Evaluation of the cytotoxicity
effect of dimethyl sulfoxide (DMSO) on Caco2/TC7 colon tumor cell
cultures. Biol Pharm Bull. 25:1600–1603. 2002. View Article : Google Scholar : PubMed/NCBI
|
33
|
Boatright KM and Salvesen GS: Mechanisms
of caspase activation. Current Op in Cell Biol. 15:725–731. 2003.
View Article : Google Scholar
|
34
|
Fusco F, Mercadante V, Miano MG and Ursini
MV: Multiple regulatory regions and tissue-specific transcription
initiation mediate the expression of NEMO/IKKγ gene. Gene.
383:99–107. 2006. View Article : Google Scholar : PubMed/NCBI
|
35
|
Shishodia S, Majumdar S, Banerjee S and
Aggarwaal BB: Ursolic acid inhibits nuclear factor-κB activation
induced by carcinogenic agents through suppression of IκBa kinase
and p65 phosphorylation: correlation with down-regulation of
cyclo-oxygenase 2, matrix metalloproteinase 9 and cyclin D11.
Cancer Res. 63:4375–4383. 2003.PubMed/NCBI
|
36
|
Chen ZJ: Ubiquitination in signaling to
and activation of IKK. Immunol Rev. 246:95–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
37
|
Liu S, Lv J, Han L, Ichikawa T, Wang W, Li
S, Wang XL, Tang D and Cui T: A pro-inflammatory role of
deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth
muscle cells. Biochem Biophys Res Commun. 420:78–83. 2012.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Wang Q, Yuan L, Liu Z, Jiang X and Lu J:
Expression of A20 is reduced in pancreatic cancer tissues. J Mol
Histol. 43:319–325. 2012. View Article : Google Scholar : PubMed/NCBI
|
39
|
Schmukle AC and Walczak H: No one can
whistle a symphony alone-how different ubiquitin linkages cooperate
to orchestrate NF-κB activity. J Cell Sci. 125:549–559. 2012.
View Article : Google Scholar : PubMed/NCBI
|